NCT01100320View on ClinicalTrials.gov

A Study to Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

March 31, 2007

Study Completion Date

July 31, 2007

Conditions
Healthy Volunteers
Interventions
DRUG

Reformulated OXY (oxycodone HCl)

Reformulated OXY 40-mg tablet x 1 dose taken with food

DRUG

Original OxyContin® (OXY) (oxycodone HCl)

Original OxyContin® (OXY) 40-mg tablet x 1 dose taken with food

Trial Locations (1)

78752

Covance Clinical Research Unit - Austin, Austin

All Listed Sponsors
lead

Purdue Pharma LP

INDUSTRY

NCT01100320 - A Study to Determine the Fed Bioequivalence of Reformulated OXY Tablets and Original OxyContin® (OXY) Tablets | Biotech Hunter | Biotech Hunter